Predicine Submits First PMA Module to FDA for Bladder Cancer Companion Diagnostic
The urine-based NGS assay received Breakthrough Device Designation in 2022 and targets genomic alterations in cancer-associated genes.
Category: Sequencing Systems
Sequencing Systems
Latest
Sequencing Systems
Latest
Blood Test May Detect Leukemia Risk
A new study reveals that a simple blood test using single-cell sequencing of rare stem cells can detect early signs of leukemia.
Sequencing Systems
Latest
UG 100 Solaris Increases Output, Lowers Sequencing Costs
Ultima Genomics has launched UG 100 Solaris, an upgraded sequencing solution that enhances throughput and reduces costs.
Genomic Sequencing Platform Found Effective for Newborn Screening
Two studies demonstrate the potential of a genomic screening platform to improve early detection of genetic diseases in newborns.
Read More
Delve Bio Launches Genomic Infectious Disease Test Delve Detect
Delve Bio’s Delve Detect is a metagenomic sequencing test capable of quickly identifying over 68,000 pathogens from CSF.
Read More
Genomic Test Rapidly Identifies Pathogens Behind Neurological and Respiratory Infections
A mNGS test offers a rapid, comprehensive solution to diagnose a broad range of pathogens in neurological and respiratory infections.
Read More
How Systemic Barriers Cause Racial Disparities in Genetic Diagnosis
A study reveals that while diagnostic accuracy in genetic testing is consistent across racial groups, access disparities persist.
Read More
Biotia’s Genomics-Based Urine Test Gains New York State Approval
Biotia’s BIOTIA-ID Urine NGS Assay uses artificial intelligence (AI) and genomics to deliver rapid, highly accurate UTI diagnoses.
Read More
Illumina Launches New Series of Benchtop Sequencing Systems
Illumina’s new MiSeq i100 Series sequencing systems provide faster, simpler, and more cost-efficient next-generation sequencing solutions.
Read More
Healthcare-Associated Infections Can Be Reduced with DNA Sequencing
Reducing the incidence of healthcare-associated infections, and the antimicrobial resistance they can trigger, is critical for patient care.
Read More
NeoGenomics Launches New Sequencing Assay for Rapid Genetic Profiling of AML
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read More
Breakthroughs in Diagnosing Colorectal Cancer with Rare Genetic Variants
A new study emphasizes the potential of advanced sequencing techniques in improving outcomes for CRC patients with rare genetic variants.
Read More
Ambry Genetics Announces New Multiomic Exome Test for Improved Rare Disease Detection
Ambry Genetics unveiled a new multiomic exome sequencing test that incorporates RNA analysis to enhance the detection of rare diseases.
Read More
GeneDx Announces Whole Genome Sequencing Product Enhancements to Accelerate Diagnoses
GeneDx announced enhancements to its whole genome sequencing services, all aimed at accelerating diagnoses and improving health outcomes.
Read More
Baylor Genetics and Baylor College of Medicine Launch New Lab
Baylor Genetics and Baylor College of Medicine have launched the Medical Genetics Multi-Omics Laboratory to innovate genetic testing.
Read More
Unlock Behind the Seizure Program Provides Testing for Pediatric Epilepsy
The Unlock Behind the Seizure program aims to provide accessible and affordable genetic testing for pediatric epilepsy patients.
Read More
Whole Genome Sequencing Improves Pediatric Cancer Care
Whole genome sequencing has improved care for some children with cancer in England and can potentially replace multiple standard tests.
Read More
Rapid Cerebrospinal Fluid Test Decreases Time for Brain Tumors Diagnosis
A new genotyping test using cerebrospinal fluid can rapidly diagnose brain cancers, reducing the need for invasive biopsies.
Read More